Video

Thoughts on AAO 2020: Uveitis Subspecialty Day

Author(s):

A uveitis specialist breaks down what occurs during the uveitis-dedicated event and comments on its importance.

Every other year, the American Academy of Ophthalmology (AAO) hosts a Uveitis Subspeciality Day as part of its larger conference agenda. The event allows ophthalmologists of all specialties and backgrounds an opportunity to stay up to date with the latest developments and trends in uveitis practice.

Events this year included sessions on anterior uveitis, panuveitis, and as well as a lecture on the future state of uveitis. One session featured talks on surgeries involving cataracts and glaucoma as well as specific case presentations.

In an interview with HCPLive®, Lynn Hassman, MD, PhD, Assistant Professor, Ophthalmology and Visual Sciences, Washington University School of Medicine, talked about the importance of the day for general ophthalmologists, trainees, and uveitis physicians.

“It’s very practical, but there are also tidbits there for practitioners at every level,” Hassman noted.

She explained that the meeting is run, proctored, and moderated by experts in the field with many years of experience.

Many of the cases presented during the meeting involved the most common uveitis scenarios encountered by virtually all ophthalmologists. From there, the presentations tackled other more in-depth topics — such as cases related to posterior uveitis and the retina.

The meeting also provided insight into how to properly diagnose cases, triage, and prescribe treatments.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.